Previous Article | Next Article ![]()
Infection and Immunity, October 2001, p. 6231-6239, Vol. 69, No. 10
Department of Molecular Virology and
Microbiology, Baylor College of Medicine, Houston, Texas
Received 8 March 2001/Returned for modification 21 May
2001/Accepted 13 July 2001
The leukotoxin of Mannheimia haemolytica is an
important virulence factor that contributes to much of the pathology
observed in the lungs of animals with bovine shipping fever pneumonia. We believe that identification of factors that regulate leukotoxin expression may provide insight into M. haemolytica
pathogenicity. The DNA sequence upstream of the leukotoxin operon is
divergently shared by PlapT, which transcribes
an arginine permease gene. The intergenic region contains several
elements that are potential sites for transcriptional modulation of the
promoters. We have developed plasmid-borne chloramphenicol
acetyltransferase (cat) operon fusions, as well as
lktC::cat chromosomal fusions, to study transcription initiation in M. haemolytica.
Using these genetic tools, we have identified cis-acting
sequences and environmental conditions that modulate transcription of
the leukotoxin and lapT promoters. By deletion analysis,
promoters were shown to rely on sequences upstream of their Mannheimia
(Pasteurella) haemolytica serotype A1 is the
major bacterial pathogen involved in a respiratory disease known as bovine shipping fever pneumonia (13). M. haemolytica is normally a commensal bacterium of the upper
respiratory tracts of healthy ruminant animals (12).
However, when the animals have a predisposing viral infection and/or
are exposed to stress, the lungs can become infected with M. haemolytica and cause pneumonia. This disease has a significant
effect on the cattle industry in terms of population morbidity and
mortality and economic losses (16, 21). Characteristics of
the disease include necrosis, fibrinous pleuritis, and infiltration of
inflammatory cells (8).
Much of the lung pathology observed in shipping fever pneumonia is
attributed to the leukotoxin of M. haemolytica. Leukotoxin lyses bovine leukocytes and platelets (5, 38), and at
sublytic concentrations, leukotoxin can cause apoptosis, neutrophil
activation, and inflammatory mediator release (6, 35, 40).
While M. haemolytica is part of the normal flora of the
upper respiratory tracts of cattle, the destructive effects of
leukotoxin are not observed there. Pathogenicity of M. haemolytica is marked by rapid replication, subsequent inhalation
of the organism into the lungs, and expression of leukotoxin.
Therefore, investigation of the regulation of leukotoxin could help our
understanding of how M. haemolytica switches from a
nonpathogenic to a virulent organism.
Leukotoxin is expressed from an operon containing genes necessary for
posttranslational activation (lktC) of the protoxin (lktA) and its secretion (lktBD) (18,
28). Leukotoxin is a member of the RTX (repeats in toxin) family
of cytolysins, based on structural characteristics of the toxin,
genetic organization, and cytotoxic activity (47). Other
RTX family members include the hemolysin from Escherichia
coli (HlyA), the leukotoxin of Actinobacillus
actinomycetemcomitans (LtxA), the Bordetella pertussis adenylate cyclase-hemolysin (CyaA), the iron-regulated proteins FrpA
and FrpC of Neisseria meningitidis, and the recently
identified RtxA protein of Vibrio cholerae (11, 14,
24, 26, 41). RTX toxins are regulated at the level of
transcription by a diverse array of cis- and
trans-acting factors. It is understandable that expression
of RTX toxins would be tightly controlled by multiple factors and
perhaps regulated coordinately with other virulence genes.
The leukotoxin of M. haemolytica appears to have a very
complex promoter region. The leukotoxin operon (lktCABD) is
preceded by a 406-bp intergenic region (Fig.
1A). Within this sequence, the leukotoxin
operon uses a cytosine residue at position
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6231-6239.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Use of Operon Fusions in Mannheimia
haemolytica To Identify Environmental and
cis-Acting Regulators of Leukotoxin
Transcription
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
10 and
35 regions for full activity. Direct repeats of the sequence
TGT-N(11)-ACA and a static bend region caused by phased
adenine tracts were necessary for full activation of
Plkt. A computer-generated model of the promoter's structure shows how DNA bending brings the repeat sequences within close proximity to the Plkt RNA
polymerase, and we hypothesize that these repeats are a binding site
for an activator of leukotoxin transcription. The
lktC::cat operon fusion was
also used to demonstrate that, like that of other RTX toxins,
leukotoxin transcription is environmentally regulated. Roles for iron
deprivation and temperature change were identified.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
30 relative to the first
amino acid codon (ATG) as its transcriptional start site
(18). The gene for an L-arginine
binding protein, lapT, is transcribed in the opposite
direction, starting at position
349 relative to the lkt
transcriptional start site (20). lapT is the
first gene of a four-gene cluster involved in arginine binding and
transport (4). Sequence inspection revealed several elements that may be involved in regulation of transcription of the
leukotoxin operon and the arginine permease locus (19). Plkt has an extended
10 promoter sequence,
TGNTATAAT, found in E. coli promoters that lack a consensus
35 region and that rely on upstream activators for transcription
initiation (25). Plkt does not have
a recognizable
35 region; however, at positions
47 to
96 are four
adenine tracts that cause the promoter to bend approximately 80°.
This intrinsic bending of the DNA has been implicated in promoter
activation (19). Upstream of the adenine tracts are three
direct repeats, A1, A2, and A3, of the sequence
TGT-N(11-12)-ACA that may function as binding
sites for a regulatory protein (19). The E. coli DNA-bending protein integration host factor (IHF) binds to
the intergenic region, and a near-consensus IHF binding site is
observed at positions
237 to
251 (19). Another
potential regulatory site within the promoter is a near-consensus
binding site for the iron regulator protein Fur. A computer-generated
model of the region, based on individual contributions of base pairs to DNA bending, shows the intrinsic curvature of the DNA. Figure 1B
displays the location of the cis elements mentioned above
and their predicted spatial relationship to one another.

View larger version (40K):
[in a new window]
FIG. 1.
(a) Nucleotide sequence of the
lapT-lktC intergenic regulatory region of
M. haemolytica SH1217. Bolded cytosine residues indicate
the transcriptional start sites of PlapT and
Plkt. The sequence is numbered in reference to
the Plkt transcriptional start site at +1.
Underlined nucleotides indicate the predicted
10 promoter regions of
PlapT and Plkt. Shaded
nucleotides correspond to the four phased adenine tracts. Putative
upstream activator sites A1, A2, and A3 are boxed. The near-consensus
IHF binding site is indicated with a dotted line above the sequence,
and a potential Fur binding site is marked above the nucleotides
(



). Unique enzyme restriction sites are shown.
(b) Computer-predicted DNA structure of the 0.4-kb
lapT/lktC promoter region that was generated by
the CURVATURE program (42). Two different views were
created by rotating the image along its x axis by using
RasMac v2.6 (37). The image on the right has been reduced
in size. Sequence elements are noted on the model. IHF and FUR are
potential IHF and FUR binding sites, and A-tracts are adenine tracts.
Solid arrows show the direction of transcription.
Expression of virulence factors in response to environmental changes is a common theme in microbial pathogenesis (29). During the disease state, M. haemolytica experiences dramatic changes in its physical environment. At the onset of disease, M. haemolytica has a phase of rapid growth. The bacteria are then inhaled into the lung, where they encounter an environment different from that in the nasopharynx. It can be expected that the bacteria experience changes in temperature, oxygen concentration, and availability of nutrients and molecules such as iron. In addition, the bacteria face the host immune response and the need to elaborate defenses. Variations in the microenvironment of M. haemolytica may be a cue to modulate leukotoxin expression.
Previous studies of transcription in M. haemolytica were difficult and limited to Northern analysis (18, 39). As described here, we can now quantitate gene expression in M. haemolytica by using chloramphenicol acetyltransferase (CAT) operon fusions. In this study, we began to address M. haemolytica pathogenicity by studying virulence control at the level of transcription. Because transcription of virulence genes is often coordinately regulated, information gained about leukotoxin transcription may provide insight into the overall transition toward pathogenicity. Here we describe cis elements and environmental cues that regulate initiation at the leukotoxin promoter.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and growth conditions.
All of the
bacterial strains used in this study are listed in Table
1. For standard growth of M. haemolytica cells, a culture was streaked from frozen stocks onto
5% sheep blood agar and incubated at 37°C overnight. Colonies from
fresh plates were then grown at 37°C in 25 ml of brain heart infusion
broth (BHI; Difco, Detroit, Mich.) in 125-ml flasks and shaken at 200 rpm. For iron depletion studies, iron was chelated by adding 10 to 250 µM 2,2-dipyridyl (Sigma, St. Louis, Mo.). Iron repletion was
performed by adding 200 µM FeCl3 to BHI
containing either 100 or 250 µM 2,2-dipyridyl. Temperature shift
assays were performed either by growing M. haemolytica cells
at 37°C continuously or by growing the bacteria at 30°C until
mid-log phase and then shifting the temperature to 37°C. When
antibiotics were necessary for plasmid selection or maintenance in
M. haemolytica, cells were grown in ampicillin (AP) at 25 µg/ml, streptomycin (SM) at 100 µg/ml, or chloramphenicol (CM) at 5 µg/ml. E. coli strain XL1-Blue (Stratagene, La Jolla,
Calif.) was used for cloning. For E. coli, antibiotics were
used at the following concentrations: AP at 100 µg/ml, CM at 20 µg/ml, tetracycline at 15 µg/ml, and kanamycin at 25 µg/ml.
|
DNA manipulations.
The oligonucleotides used in this study
are listed in Table 1. The plasmids used in this study are listed and
described in Table 1, Fig. 2, or Fig. 5A.
Plasmids were created and isolated by using standard DNA manipulation
techniques (36). To create cat reporter plasmid
pAM2355, plasmid pTP128 (generously provided by T. Palzkill; Baylor
College of Medicine, Houston, Tex.) was digested with KpnI
to obtain a 0.2-kb fragment containing
trrnB from E. coli. The
KpnI fragment was then ligated into the KpnI site
on pNF2283 upstream of the cat gene (Fig. 2) (10). To create Plkt and PlapT operon
fusion plasmids pAM2364 and pAM2365, respectively, the 412-bp
intergenic region from ATG to ATG was PCR amplified with
oligonucleotides SH141 and SH142 by using the SH1217 chromosome as
template DNA and then digested with BamHI and ligated into
the BamHI site of pAM2355 (Fig. 2). To create
lktC::cat chromosomal fusions, a
plasmid for homologous recombination was constructed. A 1.6-kb
PvuII fragment of pNF2237, containing a portion of the
cat gene and downstream leukotoxin operon sequences, was
ligated to pAM2364 cut with PvuII and EcoRV. The
resulting plasmid, pAM2434, contained the flanking 3' sequence for
chromosomal recombination (see below) while maintaining the identical
operon fusion used for plasmid studies described in this paper.
|
Primer extension.
Transcriptional start sites were mapped by
primer extension using a primer specific for the cat gene.
Total RNA was obtained by using the RNeasy Maxi Kit (Qiagen, Valencia,
Calif.), and RNA was quantitated by measuring the
A260. Oligonucleotide SH186 (0.01 µg) was 5' labeled with 25 pmol of
[
-32P]ATP (6,000 Ci/mmol, 10 mCi/ml) using
10 U of T4 polynucleotide kinase (Promega, Madison, Wis.). Primer
extension was performed as recommended by the supplier, by using avian
myeloblastosis virus reverse transcriptase (Promega), 1 pmol of labeled
primer SH186, and 10 µg of total RNA. Reverse transcription was
carried out at 47°C for 30 min.
CAT assay.
To monitor transcription, a liquid diffusion CAT
assay was modified for M. haemolytica (9, 32).
For studies throughout all growth phases, fresh BHI was inoculated with
a 1:50 dilution of an overnight culture. At various times, cells were
collected for cell density measurements and lysate preparation. All
samples were normalized to an optical density at 600 nm of 0.3, and
then cells were centrifuged and washed in 0.5 ml of cold buffer (0.1 M
Tris-HCl, pH 7.8). After washing, the cells were resuspended in 0.1 ml
of cold buffer plus 1 mM dithiothreitol and immediately stored at
20°C. After all of the samples had been collected, lysates were
made and CAT activity was measured. Cell lysates were prepared by
adding 200 µg of lysozyme per ml and 2% Triton X-100 to each sample,
mixing the combination, and then incubating the mixture on ice for 10 min. Cell debris was removed by centrifugation, and supernatants were
collected and used immediately. At precise 1-min intervals, 5 µl of
cell lysate or lysate diluted in 0.1 M Tris was added to 250 µl of
CAT reaction mixture (2.0 ml of 0.1 M Tris-HCl [pH 7.8], 0.5 ml of 5 mM CM [dissolved in distilled H2O], 2 µl of
[3H]acetyl coenzyme A [200 mCi/mmol, 1 mCi/ml]; ICN Biomedicals, Inc., Irvine, Calif.) in 5-ml plastic
scintillation vials. Three milliliters of scintillation fluid
(Econofluor; Packard) was then overlaid onto the reaction mixture.
Samples were incubated at room temperature for 30 min and then counted
for 1 min using a scintillation counter (Beckman LS 7500). To verify
response linearity, samples were counted again at 1-h intervals for up
to 4 h. CAT activity is expressed as CAT units per unit of optical
density at 600 nm. CAT units = [(cpm
control)/(3H
counting efficiency)]/(time × 0.44 dpm/nmol).
Construction of chromosomal operon fusions. Chromosomal lktC::cat operon fusions were created by using a method previously described (9). M. haemolytica strain SH1217 carrying Apr plasmid pAM2434, pAM2516, or pAM2518 was transformed with incompatible Smr plasmid pYFC1. Double transformants were selected on AP SM blood agar plates. Colonies were pooled together and propagated overnight in 5 ml of BHI containing SM at 100 µg/ml. Approximately 103 cells from the overnight culture were plated on blood agar plates containing SM at 100 µg/ml and CM at 5 µg/ml (except for cells carrying pAM2518, which was Cms) and incubated overnight at 37°C. Colonies were screened for loss of hemolysis, indicating chromosomal rescue of the cat gene at the leukotoxin locus. Candidate colonies were replica plated onto AP at 25 µg/ml to confirm loss of plasmid DNA. Colonies that were nonhemolytic and Smr Aps were grown for 8 h in novobiocin at 20 µg/ml to cure cells of pYFCI. Sms Cmr Aps strains SH2020 and SH2410 and Sms Cms Aps strain SH2405 were chosen for further characterization.
| |
RESULTS |
|---|
|
|
|---|
Creation of reporter plasmids and strains. Previously, the ability to perform transcriptional analysis in M. haemolytica was limited by the lack of a manipulable reporter gene system. We have created a promoter probe vector to quantitate transcription in M. haemolytica by using the cat reporter gene. Plasmid pNF2283, which contains a promoterless cat cassette and a 3' transcription terminator, was modified by adding a terminator, trrnB, upstream of the cat gene to prevent possible transcriptional readthrough from the vector (10). This modified promoter probe vector, pAM2355, can be used in both M. haemolytica and E. coli to monitor transcription (Fig. 2). First we cloned a 695-bp DNA fragment containing the 406-bp intergenic promoter region and portions of the lapT and lktC genes upstream of the cat cassette in pAM2355. Transformation of this plasmid into M. haemolytica and E. coli cells resulted in poor cell growth (data not shown). We had previously observed cell toxicity when the lktC gene was overexpressed, so we next created operon fusions that contained only the PlapT-Plkt intergenic region. The resulting plasmids directed transcription of the cat gene either by Plkt on pAM2364 or by PlapT on pAM2365 (Fig. 2). Creation of such operon fusions containing only the region from the PlapT ATG codon to the Plkt ATG codon allowed us to focus our studies on transcriptional initiation rather than initiation plus elongation.
We chose to use the multicopy plasmid operon fusions to study transcription because of their ease of manipulation for mutagenesis. Nevertheless, to validate our results, we also created a single-copy chromosomal leukotoxin::cat operon fusion in M. haemolytica. The lktC::cat fusion from pAM2364 was crossed to the chromosomal leukotoxin locus by a previously described method (9). Recombination was detected by loss of hemolytic activity on blood agar plates as a result of inactivation of the lktC posttranslational leukotoxin activator gene. Strain SH2020 carrying a chromosomal lktC::cat operon fusion was selected, and the fusion was confirmed by PCR and DNA sequencing (data not shown). The transcriptional start site of Plkt, from both plasmid and chromosomal operon fusions, was mapped by primer extension. Previously, the leukotoxin transcriptional start site was mapped to one of two cytosine residues at position
30 or
31
relative to the transcriptional start site (18). As shown
in Fig. 3, transcription of the
leukotoxin promoter on pAM2364 begins at the cytosine residue at
position
30. The transcriptional start site of the chromosomal operon
fusion SH2020 was similarly mapped by primer extension and occurred at
the same residue as in pAM2364 (data not shown). The primer extension
product was quantitated by densitometry and was 10-fold higher when
plasmid borne (data not shown). This was expected, since we have
predicted that the copy number of pYFCI-based plasmids is approximately
8 to 10 plasmids per cell (S. K. Highlander, unpublished results).
No primer extension product was observed when we used RNA from M. haemolytica cells containing the reporter vector pAM2355 (data not
shown). Our results indicate that both the plasmid and chromosomal
operon fusions utilize the same start site as the wild-type leukotoxin
promoter. Plasmids were used for promoter mutational analysis, and
activity was confirmed when necessary by using chromosomal operon
fusions. Strain SH2020 was used to study the effects of environmental
changes on leukotoxin transcription.
|
Plkt and PlapT
activity in M. haemolytica
For initial
characterization of Plkt and
PlapT transcription, we monitored CAT activity
in BHI at 37°C during the lag, log, and stationary phases of growth.
M. haemolytica cells harboring either lkt
reporter plasmid pAM2364 or lapT reporter plasmid
pAM2365 were grown, samples were taken at various time points
throughout growth, and promoter activity was determined by CAT assay
(Fig. 4). Although we had expected that
Plkt would be modulated by growth phase, we
observed that Plkt expression was constant
through all phases of growth in BHI. This could represent maximal or
basal transcription in a rich, undefined medium, suggesting that
additional experiments under different growth conditions might be
necessary to demonstrate differential expression. Expression of the
lapT promoter in BHI did, however, vary as a function of
growth phase. lapT promoter activity decreased twofold
during early log phase and then increased as the cells entered
stationary phase. Vector plasmid pAM2355, which lacks a promoter, had
no significant CAT activity in M. haemolytica (data not
shown). The growth curves of all three strains were identical.
|
Deletion analysis of Plkt and
PlapT.
To identify sequence elements
important for regulation of transcription from
Plkt and PlapT, we
mutagenized the region and then examined CAT activity. We chose to
create deletions within the region rather than use site-directed
mutagenesis of putative regulatory motifs. Nested deletions of the
promoters were created by restriction digestion at unique sites within
the PCR-amplified promoter fragment. Each deletion removed sequence elements that were approximately 50-bp apart (Fig.
5A). By measuring the transcriptional
activity of the deleted fragments, we identified several regions that
appear to be involved in regulation. The SspI deletion
fragment directed a wild-type level of activity, suggesting that it
contains all of the sequences required for transcription. Surprisingly,
the BpiI and HinfI deletion fragments, which
include additional upstream regions, had reduced expression. Apparently, loss of the lapT initiation region had a
negative effect on transcription of the downstream leukotoxin promoter. Nevertheless, as expected, deletion of the A2 and A3 protein binding sites (DraI deletion) reduced transcription by 32%. Further
deletion of the static DNA bend (Sau3A deletion) reduced
transcription to 8% of the wild-type level (Fig. 5A).
|
Environmental regulation of Plkt.
Because promoter elements observed within the intergenic region
suggested some level of transcriptional control, we were interested in
identifying environmental cues that might be involved. CAT assays were
performed by using chromosomal operon fusion strain SH2020 grown under
various conditions. The conditions tested included iron depletion,
temperature variation, minimal medium, varied pH, and anaerobiosis. To
test the effects of iron depletion on leukotoxin transcription, cells
were grown in the presence of the iron chelator 2,2-dipyridyl. As the
2,2-dipyridyl concentration increased, so did leukotoxin promoter
activity (Fig. 6). At 250 µM, promoter
activity increased more than threefold. Cell density was not affected
by growth in the presence of 250 µM 2,2-dipyridyl, although higher
concentrations inhibited growth. When cells were grown in iron-replete
medium created by adding 200 µM FeCl3 to 2,2-dipyridyl-treated medium, transcription decreased to the level seen
in cells grown in iron-rich BHI (Fig. 6).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Until now, studies of promoter regulation in M. haemolytica were limited due to the lack of appropriate genetic tools. We have created a cat promoter probe vector that is easily manipulated in E. coli, and transcription from the promoter can be monitored in M. haemolytica by CAT assay. We have used this system to study the divergent leukotoxin and lapT promoters. Identification of the regulatory cues and components of leukotoxin transcription may provide information regarding the transcription of other M. haemolytica virulence factors and a possible master "virulence switch."
The discovery of global regulators and coordinately controlled virulence genes has been an important step in understanding the pathogenicity of an organism. When the bacterium encounters a change in its environment, whether within or outside of a host, a subset of genes is often coregulated to ensure the survival of the organism (30). M. haemolytica may transcriptionally regulate a variety of genes when it enters the lungs in order to survive the change in its environment from that of the nasopharynx. We suspect that leukotoxin is one of many genes regulated at this stage.
Most of the RTX toxins studied are regulated at the level of transcription initiation and/or elongation by cis, trans, and environmental factors. The plasmid-borne alpha-hemolysin of E. coli is transcriptionally enhanced by the cis element hlyR and the trans activator HlyT (2, 45). A sequence determinant within the leukotoxin promoter of A. actinomycetemcomitans has a significant effect on transcription. Variations in promoter sequence are strain specific and correlate with leukotoxin expression levels and periodontal disease (23). Environmental control of RTX toxin transcription is exemplified by the frp genes of N. meningitidis, which are up-regulated under iron-limiting conditions, and the E. coli hly genes, which are regulated by temperature, osmolarity, and anaerobiosis (31, 41). The adenylate cyclase-hemolysin of B. pertussis is trans regulated by the BvgAS two-component regulatory system, which senses environmental conditions and differentially expresses appropriate genes (43).
Our study indicates that the leukotoxin of M. haemolytica is
also regulated at the level of transcription. The leukotoxin promoter
contains DNA sequence elements upstream of the
10 and
35 regions
that are required for full promoter activity. One of these regions, the
A2 and A3 direct repeats of the sequence TGT-N-ACA, has been shown in
other systems to act as a binding site for trans regulator
proteins. In Rhodobacter sphaeroides 2.4.1, the sequence
TGT-N12-ACA is necessary for PpsR repression of
the puc operon involved in photopigment biosynthesis
(15). The sequence TGT-N12-ACA acts
as a binding site for the P2 Org family of activators involved in
transcription of the late promoters of bacteriophages P2 and P4
(17, 22). The motif is also recognized by NifA of
Klebsiella pneumoniae, where it is involved in the regulation of nitrogen fixation genes (3). We know that
the A2 and A3 direct repeats of the leukotoxin promoter are binding sites for an M. haemolytica-specific protein
(19), and based on our deletion analysis, the site appears
to be involved in positive regulation.
The lapT initiation region appears to have an effect on
Plkt transcription. Deletion of the region
containing the lapT promoter and the putative IHF binding
site negatively affected leukotoxin transcription. However, a more
extensive deletion (
SspI) restored wild-type levels of
expression. It is possible that protein bound between the
HinfI and SspI sites can repress
Plkt transcription in the absence of the
divergent lapT promoter. Removal of such a repressor binding
site could restore full activity to the promoter. Alternatively, the
deletion may topologically destabilize the promoter, resulting in
reduced Plkt transcription. Nevertheless,
wild-type levels of Plkt transcription can occur
when the fragment contains the putative activator sites A2 and A3 and
downstream sequences. In our model (Fig.
8), leukotoxin transcription is activated
or enhanced by a protein bound to sites A2 and A3. The static DNA bend
acts to facilitate the interaction of the putative activator with RNA
polymerase. We hypothesize that both the bend and the activator can
enhance RNA polymerase binding and may stabilize open-complex
formation. It is important to note that for both the lapT
and lkt promoters, the smallest fragments tested,
BpiI and Sau3A, respectively, had less than 10%
of the activity of the complete sequences. This implies that the
10
and
35 sequences are not sufficient for maximal promoter activity, in
support of our activation hypothesis.
|
Environmental signals have been shown to influence virulence gene
expression in several different organisms (29). For
example, when bacterial cells are starved for iron, such as those
within a mammalian host, they elicit several responses to acquire iron from their surroundings. In some organisms, the response is increased expression of RTX toxins and hemolysins (27) that can lyse
host cells and cause them to release their internal stores of iron. Our
studies show that a decrease in iron concentration causes increased
transcription of the M. haemolytica leukotoxin promoter, both on the chromosome (Fig. 6) and on plasmids (data not shown). In
contrast, a previous report indicated that iron depletion resulted in a
decrease in leukotoxin mRNA and secreted protein (39). However, it is reasonable to expect that M. haemolytica
would need to increase its ability to scavenge iron due to competition and hypoferremia induced by host cytokines during infection
(46). Nucleotides
15 to
33 of the leukotoxin promoter
contain a sequence similar to the consensus "iron box" that is
bound by the Fur repressor (Fig. 1). Fur could be the protein
responsible for the iron-dependent regulation that we observed. A role
for Fur repression could not be proven by our deletion study because
the iron box is contained within the Sau3A fragment and this
promoter fragment would remain repressed in the presence of iron.
Site-directed mutation of the potential Fur binding site would be
expected to increase expression of leukotoxin under iron-rich conditions.
Neither the level of oxygenation nor the pH of the medium had an effect on leukotoxin transcription, although previous reports had suggested roles for these conditions. Anaerobic modulation was hypothesized based on a recent report linking the ferric nitrate regulator Fnr to the transcription of leukotoxin (44). When fnr was cloned in E. coli, no differential regulation was observed under anaerobic conditions, but when the M. haemolytica Fnr homologue FnrP was coexpressed in E. coli, transcription was activated about fivefold. The relevance of this observation to leukotoxin transcription in M. haemolytica remains to be determined. Likewise, we did not observe a difference in leukotoxin promoter activity when the pH of the medium was altered. This is in contrast to a study by Strathdee and Lo that showed increased leukotoxin mRNA when cultures were shifted from pH 6.5 to pH 7.3 (39). Because our experiments used steady-state cultures and not pH shifts, the results observed by Strathdee and Lo may have been transient and therefore would not be detected in our system.
In support of the results presented by Strathdee and Lo (39), leukotoxin transcription was affected by temperature. Shifts from a low-temperature to a higher-temperature environment resulted in an increase in promoter activity. Although growth rates differed between 30 and 42°C, we do not believe that the results are related to this because initiation is constant during all phases and rates of growth (Fig. 4). Furthermore, in our anaerobic studies, the growth rate was significantly reduced and leukotoxin transcription was not affected. The E. coli plasmid-borne hemolysin has also been shown to be thermoregulated (31). In E. coli, this effect is due to Hha and HNS, two temperature-dependent DNA binding proteins (33, 34). HNS does not have a sequence-specific binding site but, instead, prefers to bind to AT-rich DNA or bent DNA such as that found in the M. haemolytica leukotoxin promoter. As the temperature increases, HNS loses its ability to bind DNA, causing a release of repression. Using both chromosomal and plasmid operon fusions in an hns mutant E. coli strain, we observed an increase in leukotoxin relative to that of a wild-type host at 30°C (A. M. Marciel, L. Alvarez, and S. K. Highlander, unpublished data). Thus, like the E. coli hemolysin, HNS may repress leukotoxin transcription at low temperatures.
Information gained from our plasmid operon fusion studies and previous studies in our laboratory have also provided us with a working model for lapT transcription (19). PlapT promoter activity was minimal in early log phase and increased toward stationary phase. This pattern parallels the protein expression of IHF in E. coli (7). Deletion of the near-consensus IHF binding site within the lapT/lkt promoter region resulted in loss of PlapT activity, indicating that IHF acts as an activator of lapT transcription (Fig. 8).
We have shown by mutational analysis and environmental variation that the lapT and lkt promoters are regulated at the level of transcription initiation. These studies were possible due to the creation of both chromosomal and plasmid-borne cat operon fusions. It appears that the leukotoxin promoter is subject to complex regulation by both repression and activation. Repression by Fur and HNS is indicated, and our deletion analysis provides support for the role of an activator. Now that certain regions have been recognized as necessary for PlapT and Plkt activity, a targeted-mutagenesis approach can be taken to specifically identify the regulating sequences. An important future step in the investigation of leukotoxin transcriptional regulation is to identify trans-acting factors from M. haemolytica that interact with the promoter. Eventually, a comprehensive understanding of M. haemolytica virulence might include a comparison of all of the genes turned on during the organism's virulent phase and identification of common factors that control their regulation.
| |
ACKNOWLEDGMENTS |
|---|
We thank Richard R. Sinden, of The Institute of Biosciences and Technology, Houston, Tex., for assistance in generating the computer topology model of the lapT/lkt promoter.
This project was funded by USDA grants 96-35204-3825 and 99-35204-7875 to S.K.H., and A.M.M. was supported by the B.C.M. M.D./Ph.D. Patent Royalties Fund.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Baylor College of Medicine Department of Molecular Virology and Microbiology, One Baylor Plaza, MS BCM280, Houston, TX 77030. Phone: (713) 798-6311. Fax: (713) 798-3735. E-mail: sarahh{at}bcm.tmc.edu.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adler, H. I. 1990. The use of microbial membranes to achieve anaerobiosis. Crit. Rev. Biotechnol. 10(2):119-127[Medline]. |
| 2. | Bailey, M. J. A., V. Koronakis, T. Schmoll, and C. Hughes. 1992. Escherichia coli HlyT protein, a transcriptional activator of haemolysin synthesis and secretion, is encoded by the rfaH (sfrB) locus required for expression of sex factor and lipopolysaccharide genes. Mol. Microbiol. 6:1003-1012[CrossRef][Medline]. |
| 3. | Cannon, W., W. Charlton, and M. Buck. 1991. Organization and function of binding sites for the transcriptional activator NifA in the Klebsiella pneumoniae nifE and nifU promoters. J. Mol. Biol. 220:915-931[CrossRef][Medline]. |
| 4. |
Caskey, L. S.,
J. G. Lamphear, and S. K. Highlander.
1996.
Binding-protein-dependent arginine transport in Pasteurella haemolytica.
Microbiology
142:1739-1747 |
| 5. | Clinkenbeard, K. D., and M. L. Upton. 1991. Lysis of bovine platelets by Pasteurella haemolytica leukotoxin. Am. J. Vet. Res. 52:453-457[Medline]. |
| 6. |
Czuprynski, C. J.,
E. J. Noel,
O. Ortiz-Carranza, and S. Srikumaran.
1991.
Activation of bovine neutrophils by partially purified Pasteurella haemolytica leukotoxin.
Infect. Immun.
59:3126-3133 |
| 7. |
Ditto, M. D.,
D. Roberts, and R. A. Weisberg.
1994.
Growth phase variation of integration host factor level in Escherichia coli.
J. Bacteriol.
176:3738-3748 |
| 8. | Dungworth, D. L. 1985. The respiratory system, p. 413-556. In K. V. F. Jubb, P. C. Kennedy, and N. Palmer (ed.), Pathology of domestic animals, 3rd ed., vol. 2. Academic Press, Inc., New York, N.Y. |
| 9. | Fedorova, N. D., and S. K. Highlander. 1997. Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin. Infect. Immun. 65:2593-2598[Abstract]. |
| 10. | Fedorova, N. D., and S. K. Highlander. 1997. Plasmids for heterologous expression in Pasteurella haemolytica. Gene 186:207-211[CrossRef][Medline]. |
| 11. |
Felmlee, T.,
S. Pellett, and R. A. Welch.
1985.
Nucleotide sequence of an Escherichia coli chromosomal hemolysin.
J. Bacteriol.
163:94-105 |
| 12. | Frank, G. H. 1989. Pasteurellosis of cattle, p. 197-222. In C. F. Adlam, and J. M. Rutter (ed.), Pasteurella and pasteurellosis. Academic Press Limited, London, United Kingdom. |
| 13. | Frank, G. H., and P. C. Smith. 1983. Prevalence of Pasteurella haemolytica in transported calves. Am. J. Vet. Res. 44:981-985[Medline]. |
| 14. | Glaser, P., H. Sakamoto, J. Bellalou, A. Ullmann, and A. Danchin. 1988. Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase- haemolysin bifunctional protein of Bordetella pertussis. EMBO J. 7:3997-4004[Medline]. |
| 15. |
Gomelsky, M., and S. Kaplan.
1995.
Genetic evidence that PpsR from Rhodobacter sphaeroides 2.4.1 functions as a repressor of puc and bchF expression.
J. Bacteriol.
177:1634-1637 |
| 16. | Gonzalez, C. T., and S. K. Maheswaran. 1993. The role of induced virulence factors produced by Pasteurella haemolytica in the pathogenesis of bovine pneumonic pasteurellosis: review and hypothesis. Br. Vet. J. 149:183-193[Medline]. |
| 17. | Grambow, N. J., N. K. Birkeland, D. L. Anders, and G. E. Christie. 1990. Deletion analysis of bacteriophage P2 late promoter. Gene 95:9-15[CrossRef][Medline]. |
| 18. |
Highlander, S. K.,
M. J. Engler, and G. M. Weinstock.
1990.
Secretion and expression of the Pasteurella haemolytica leukotoxin.
J. Bacteriol.
172:2343-2350 |
| 19. | Highlander, S. K., and G. M. Weinstock. 1994. Static DNA bending and protein interactions within the Pasteurella haemolytica leukotoxin promoter region: development of an activation model for leukotoxin transcriptional control. DNA Cell Biol. 13:171-181[Medline]. |
| 20. |
Highlander, S. K.,
E. A. Wickersham,
O. Garza, and G. M. Weinstock.
1993.
Expression of the Pasteurella haemolytica leukotoxin is inhibited by a locus that encodes an ATP-binding cassette homolog.
Infect. Immun.
61:3942-3951 |
| 21. | Jensen, R., R. E. Pierson, P. M. Braddy, D. A. Saari, L. H. Lauerman, J. J. England, H. Keyvanfar, J. R. Collier, D. P. Horton, A. E. McChesney, A. Benitez, and R. M. Christie. 1976. Shipping fever pneumonia in yearling feedlot cattle. J. Am. Vet. Med. Assoc. 169:500-506[Medline]. |
| 22. |
Julien, B., and R. Calendar.
1996.
Bacteriophage PSP3 and R73 activator proteins: analysis of promoter specificities.
J. Bacteriol.
178:5668-5674 |
| 23. | Kolodrubetz, D., J. Spitznagel, Jr., B. Wang, L. H. Phillips, C. Jacobs, and E. Kraig. 1996. cis elements and trans factors are both important in strain-specific regulation of the leukotoxin gene in Actinobacillus actinomycetemcomitans. Infect. Immun. 64:3451-3460[Abstract]. |
| 24. |
Kraig, E.,
T. Dailey, and D. Kolodrubetz.
1990.
Nucleotide sequence of the leukotoxin gene from Actinobacillus actinomycetemcomitans: homology to the alpha-hemolysin/leukotoxin gene family.
Infect. Immun.
58:920-929 |
| 25. | Kumar, A., R. A. Malloch, N. Fujita, D. A. Smillie, A. Ishihama, and R. S. Hayward. 1993. The minus 35-recognition region of Escherichia coli sigma 70 is inessential for initiation of transcription at an "extended minus 10" promoter. J. Mol. Biol. 232:406-418[CrossRef][Medline]. |
| 26. |
Lin, W.,
K. J. Fullner,
R. Clayton,
J. A. Sexton,
M. B. Rogers,
K. E. Calia,
S. B. Calderwood,
C. Fraser, and J. J. Mekalanos.
1999.
Identification of a Vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage.
Proc. Natl. Acad. Sci. USA
96:1071-1076 |
| 27. |
Litwin, C. M., and S. B. Calderwood.
1993.
Role of iron in regulation of virulence genes.
Clin. Microbiol. Rev.
6:137-149 |
| 28. |
Lo, R. Y. C.,
C. A. Strathdee, and P. E. Shewen.
1987.
Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1.
Infect. Immun.
55:1987-1996 |
| 29. |
Mekalanos, J. J.
1992.
Environmental signals controlling expression of virulence determinants in bacteria.
J. Bacteriol.
174:1-7 |
| 30. |
Miller, J. F.,
J. J. Mekalanos, and S. Falkow.
1989.
Coordinate regulation and sensory transduction in the control of bacterial virulence.
Science
243:916-922 |
| 31. |
Mourino, M.,
F. Munoa,
C. Balsalobre,
P. Diaz,
C. Madrid, and A. Juarez.
1994.
Environmental regulation of -haemolysin expression in Escherichia coli.
Microb. Pathog.
16:249-259[CrossRef][Medline].
|
| 32. | Neumann, J. R., C. A. Morency, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. Bio/Technology 5:444-447. |
| 33. | Nieto, J. M., C. Madrid, A. Prenafeta, E. Miquelay, C. Balsalobre, M. Carrascal, and A. Juarez. 2000. Expression of the hemolysin operon in Escherichia coli is modulated by a nucleoid-protein complex that includes the proteins Hha and H-NS. Mol. Gen. Genet. 263:349-358[CrossRef][Medline]. |
| 34. | Nieto, J. M., M. Mourino, C. Balsalobre, C. Madrid, A. Prenafeta, F. J. Munoa, and A. Juarez. 1997. Construction of a double hha hns mutant of Escherichia coli: effect on DNA supercoiling and alpha-haemolysin production. FEMS Microbiol. Lett. 155:39-44[Medline]. |
| 35. | Saban, R., R. V. Broadstone, M. Haak-Frendscho, S. Skoyen, J. Fialkowski, S. K. Maheswaran, D. E. Bjorling, and C. Czuprynski. 1997. Effects of Pasteurella haemolytica leukotoxin and lipopolysaccharide on histamine, prostanoid, and leukotriene release by bovine lung parenchyma in vitro. Am. J. Vet. Res. 58:1227-1231[Medline]. |
| 36. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 37. | Sayle, R. A., and E. J. Milner-White. 1995. RASMOL: biomolecular graphics for all. Trends Biochem. Sci. 20:374-376[CrossRef][Medline]. |
| 38. |
Shewen, P. E., and B. N. Wilkie.
1982.
Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes.
Infect. Immun.
35:91-94 |
| 39. |
Strathdee, C. A., and R. Y. C. Lo.
1989.
Regulation of expression of the Pasteurella haemolytica leukotoxin determinant.
J. Bacteriol.
171:5955-5962 |
| 40. | Sun, Y., K. D. Clinkenbeard, C. Clarke, L. Cudd, S. K. Highlander, and S. M. Dabo. 1999. Pasteurella haemolytica leukotoxin induced apoptosis of bovine lymphocytes involves DNA fragmentation. Vet. Microbiol. 65:153-166[CrossRef][Medline]. |
| 41. |
Thompson, S. A.,
L. L. Wang,
A. West, and P. F. Sparling.
1993.
Neisseria meningitidis produces iron-regulated proteins related to the RTX family of exoproteins.
J. Bacteriol.
175:811-818 |
| 42. |
Trifonov, E. N., and J. L. Sussman.
1980.
The pitch of the chromatin DNA is reflected in its nucleotide sequence.
Proc. Natl. Acad. Sci. USA
77:3816-3820 |
| 43. | Uhl, M. A., and J. F. Miller. 1995. Bordetella pertussis BvgAS virulence control system., p. 333-349. In J. A. Hoch, and T. J. Silhavy (ed.), Two-component signal transduction. ASM Press, Washington, D.C. |
| 44. | Uhlich, G. A., P. J. McNamara, J. J. Iandolo, and D. A. Mosier. 2000. FnrP interactions with the Pasteurella haemolytica leukotoxin promoter. FEMS Microbiol. Lett. 186:73-77[CrossRef][Medline]. |
| 45. | Vogel, M., J. Hess, I. Then, A. Juarez, and W. Goebel. 1988. Characterization of a sequence (hylR) which enhances synthesis and secretion of hemolysin in Escherichia coli. Mol. Gen. Genet. 212:76-84[CrossRef][Medline]. |
| 46. |
Weinberg, E. D.
1984.
Iron withholding: a defense against infection and neoplasia.
Physiol. Rev.
64:65-102 |
| 47. | Welch, R. A. 1991. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 5:521-528[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»